SG Americas Securities LLC boosted its position in Innophos Holdings, Inc. (NASDAQ:IPHS) by 81.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,632 shares of the specialty chemicals company’s stock after buying an additional 7,937 shares during the quarter. SG Americas Securities LLC owned approximately 0.09% of Innophos worth $531,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently made changes to their positions in the stock. Bank of New York Mellon Corp raised its holdings in Innophos by 3.8% in the third quarter. Bank of New York Mellon Corp now owns 402,003 shares of the specialty chemicals company’s stock valued at $17,849,000 after acquiring an additional 14,662 shares in the last quarter. Legal & General Group Plc raised its holdings in Innophos by 8.1% in the third quarter. Legal & General Group Plc now owns 46,282 shares of the specialty chemicals company’s stock valued at $2,049,000 after acquiring an additional 3,457 shares in the last quarter. Morgan Stanley raised its holdings in Innophos by 31.5% in the third quarter. Morgan Stanley now owns 101,185 shares of the specialty chemicals company’s stock valued at $4,493,000 after acquiring an additional 24,241 shares in the last quarter. Vanguard Group Inc. raised its holdings in Innophos by 2.0% in the third quarter. Vanguard Group Inc. now owns 2,065,439 shares of the specialty chemicals company’s stock valued at $91,705,000 after acquiring an additional 41,101 shares in the last quarter. Finally, Teachers Advisors LLC raised its holdings in Innophos by 4.3% in the third quarter. Teachers Advisors LLC now owns 37,859 shares of the specialty chemicals company’s stock valued at $1,681,000 after acquiring an additional 1,550 shares in the last quarter. 93.41% of the stock is currently owned by institutional investors and hedge funds.
Several analysts have weighed in on IPHS shares. BidaskClub upgraded shares of Innophos from a “sell” rating to a “hold” rating in a research note on Friday, March 29th. Seaport Global Securities started coverage on shares of Innophos in a research note on Thursday, February 21st. They set a “buy” rating for the company. TheStreet lowered shares of Innophos from a “b-” rating to a “c+” rating in a research note on Thursday, May 23rd. Finally, Zacks Investment Research lowered shares of Innophos from a “hold” rating to a “sell” rating in a research note on Saturday, March 2nd. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and one has given a buy rating to the company’s stock. The stock has a consensus rating of “Hold”.
Shares of Innophos stock traded down $0.35 during trading on Friday, hitting $27.65. 35,353 shares of the stock were exchanged, compared to its average volume of 103,575. The firm has a market capitalization of $550.36 million, a P/E ratio of 12.13 and a beta of 1.41. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.49 and a current ratio of 3.14. Innophos Holdings, Inc. has a 12 month low of $22.57 and a 12 month high of $50.40.
Innophos (NASDAQ:IPHS) last released its quarterly earnings results on Tuesday, April 30th. The specialty chemicals company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.43 by $0.14. The business had revenue of $191.41 million during the quarter, compared to analyst estimates of $199.90 million. Innophos had a net margin of 4.30% and a return on equity of 13.09%. The company’s quarterly revenue was down 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.61 earnings per share. As a group, sell-side analysts forecast that Innophos Holdings, Inc. will post 2.36 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, June 7th. Stockholders of record on Friday, May 17th were given a dividend of $0.48 per share. The ex-dividend date of this dividend was Thursday, May 16th. This represents a $1.92 annualized dividend and a dividend yield of 6.94%. Innophos’s dividend payout ratio is currently 84.21%.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Featured Article: Neutral Rating
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.